TickerWise

UFPT UFP Technologies, Inc.

$329.82+17.66%

Last close: · regular session · Last 60 sessions

After-hours $329.82 0.00% ·

Float
7.4M
Last filing
8-K · Nov 3, 2026

Latest SEC filings for UFPT

8-KCurrent report
SCHEDULE 13G/A
8-KCurrent report
10-QQuarterly report
8-KCurrent report
SCHEDULE 13G/A
8-KCurrent report
8-KCurrent report
8-KCurrent report
8-KCurrent report

Dilution today: new offering filings and reverse splits

Float: 7.4M shares. Latest SEC filing: 8-K on Nov 3, 2026. UFPT closed at $329.82 (+17.66%) on Nov 4, 2026.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for UFPT in the TickerWise workspace.

Company profile

  • Sector: Healthcare
  • Industry: Medical - Devices
  • Country: US
  • Exchange: NASDAQ
  • Employees: 4,146
  • Website: https://www.ufpt.com

UFP Technologies, Inc. designs and custom manufactures components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics primarily for the medical market. Its single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets, which are applied in military uniform and gear components, automotive interior trim, athletic padding, environmentally protective packaging, air filtration, abrasive nail files, and protective cases and inserts. It markets and sells its products in the United States principally through a direct sales force, as well as independent manufacturer representatives. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

Latest UFPT news

  • UFP Technologies: 3 Key Takeaways for Long-Term Investors Read article
  • UFP Technologies (UFPT) Q3 Earnings and Revenues Surpass Estimates Read article

Recent dilution filers

Related companies

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis